In contrast to previous studies, in which CRC cells selected for acquired resistance to 5-FU displayed elevated TS levels at baseline[34], the CRCR cells selected for acquired resistance to 5-FU/LV showed no significant increase in TS at either the mRNA or protein level in the absence of treatment. The gene discussed is TYMS; the disease is colorectal carcinoma.